Arlington-backed Everest Clinical Research acquires CRO Brightech
Arlington in 2020 made a majority investment in Everest alongside the company’s founding shareholders and senior management.
1 December 2022•2 mins read
Arlington in 2020 made a majority investment in Everest alongside the company’s founding shareholders and senior management.
Speyside Equity buys Midwest steel tubing and building products maker Tapco
7 hours ago · 2 mins read
BayPine-backed Relation Insurance buys assets of St. Louis’s Wright Insurance Planning
7 hours ago · 1 min read
Strategic Value Partners agrees to back NewEdge Power in battery storage JV
9 hours ago · 2 mins read
Oak Hill strikes deal to take majority stake in Wyyerd from Carlyle
9 hours ago · 2 mins read
Polaris Growth Fund backs commercial real estate software firm ID Plans
9 hours ago · 1 min read
Third Space Partners buys live event drape and scenic provider Quest Events
10 hours ago · 2 mins read
